Literature DB >> 19867605

THE OCCURRENCE AND VIRULENCE OF PNEUMOCOCCI IN THE CIRCULATING BLOOD DURING LOBAR PNEUMONIA AND THE SUSCEPTIBILITY OF PNEUMOCOCCUS STRAINS TO UNIVALENT ANTIPNEUMOCOCCUS SERUM.

A R Dochez1.   

Abstract

Studies of the bacteriology of the blood were made in thirty-seven cases of lobar pneumonia. The pneumococcus was isolated from the blood in approximately 50 per cent. of the cases studied. The course of infection in individuals with pneumococcus in the blood was more severe than in those in which no organism could be cultivated from the blood. 77 per cent. of the patients with positive blood cultures died, and 79 per cent. of patients with negative blood cultures recovered. In fatal instances of pneumonia, where the pneumococcus was found in the blood, the number of organisms per cubic centimeter of blood was very high in the last stage of the disease. In individuals dying of pneumonia without blood infection, the disease was characterized by a rapid spread of the local process in the lungs. It is not unlikely that the symptoms of collapse, developing on the fifth or sixth day of lobar pneumonia, are often the expression of serious invasion of the blood by the pneumococcus. In other instances, they mark an extension of the local process in the lungs. Strains of pneumococcus isolated from the blood of patients with lobar pneumonia were usually of high animal virulence. In a few instances where the organism isolated from the blood was of low virulence for animals, the patients recovered. The protective power of a univalent antipneumococcus serum was tested against nineteen strains of typical pneumococcus and against four strains of closely allied organisms. The serum manifested some degree of protection against twelve out of nineteen strains of typical pneumococci. No protection was observed against the atypical organisms. In eight instances the degree of protection obtained was high, in three low, and in one there occurred only a prolongation of the period of life of the inoculated animal.

Entities:  

Year:  1912        PMID: 19867605      PMCID: PMC2124998          DOI: 10.1084/jem.16.5.680

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  3 in total

1.  Molecular and functional characteristics of a protective human monoclonal antibody to serotype 8 Streptococcus pneumoniae capsular polysaccharide.

Authors:  Z Zhong; T Burns; Q Chang; M Carroll; L Pirofski
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

2.  Structure-function relationships for human antibodies to pneumococcal capsular polysaccharide from transgenic mice with human immunoglobulin Loci.

Authors:  Q Chang; Z Zhong; A Lees; M Pekna; L Pirofski
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

3.  Fred Neufeld and pneumococcal serotypes: foundations for the discovery of the transforming principle.

Authors:  Klaus Eichmann; Richard M Krause
Journal:  Cell Mol Life Sci       Date:  2013-05-21       Impact factor: 9.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.